BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. ✅
FEMS microbiology letters (FEMS Microbiol Lett ) Vol: 362 Issue 21 Pages: Pub: 2015 Nov Epub: 2015 Sep 28 Authors Rios-Covian D , Gueimonde M , Duncan SH , Flint HJ , de los Reyes-Gavilan CG , |
|
|
Adhesive <i>Bifidobacterium</i> Induced Changes in Cecal Microbiome Alleviated Constipation in Mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 10 Issue Pages: 1721 Pub: 2019 Epub: 2019 Aug 13 Authors Wang L , Chen C , Cui S , Lee YK , Wang G , Zhao J , Zhang H , Chen W , |
|
|
Mouse intestinal microbiome modulation by oral administration of a GABA-producing Bifidobacterium adolescentis strain. ✅
Go to Publication ✅
Microbiology spectrum (Microbiol Spectr ) Vol: 12 Issue 1 Pages: e0258023 Pub: 2024 Jan 11 Epub: 2023 Nov 22 Authors Tamés H , Sabater C , Royo F , Margolles A , Falcón JM , Ruas-Madiedo P , Ruiz L , |
|
|
Bifidobacterium adolescentis Isolated from Different Hosts Modifies the Intestinal Microbiota and Displays Differential Metabolic and Immunomodulatory Properties in Mice Fed a High-Fat Diet. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 13 Issue 3 Pages: Pub: 2021 Mar 21 Epub: 2021 Mar 21 Authors Wang B , Kong Q , Cui S , Li X , Gu Z , Zhao J , Zhang H , Chen W , Wang G , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
